Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2008
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/30/2008DE19928742B4 Neue O-Acyloxim-Photostarter New O-acyloxime photoinitiator
10/30/2008CA2684591A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/29/2008EP1984734A2 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods
10/29/2008EP1984726A2 Methods, mixtures, kits and compositions pertaining to analyte determination
10/29/2008EP1727809B8 Substituted morpholine and thiomorpholine derivatives
10/29/2008EP1492776B1 Iodinated triglyceride analogs
10/29/2008CN101296902A Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
10/29/2008CN101296897A PPAR modulating biaromatic compounds
10/29/2008CN101293880A Synthesizing method for preparing N-acryloyl morpholine
10/29/2008CN100429204C Process for the preparation of 4- (3'-chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442791 Aminoalkylamide substituted cyclohexyl derivatives
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442692 Indanyl-piperazine compounds
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/28/2008CA2331141C Water soluble azoles as broad-spectrum antifungals
10/23/2008WO2008126731A1 Aryl derivatives
10/23/2008WO2008125518A2 Process for the preparation of piperazine benzothiazoles
10/23/2008WO2008099286A3 Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008WO2008040000A3 Soluble epoxide hydrolase inhibitors
10/23/2008US20080261998 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261982 autoimmune disease and liver cirrhosis; useful for killing hyperproliferating cells
10/23/2008US20080261981 3-{4-[4-(2-amino-3-morpholin-4-yl-3-oxo-propyl)-phenoxy]-phenyl}-N-hydroxypropionamide hydrochloride; for reducing blood glucose, free fatty acids, cholesterol, triglycerides levels
10/23/2008US20080261969 1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261949 ethyl 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; tocolytics; delaying preterm birth; antidiabetic; obesity; oxyalkylation of the phenyl(alkyl)cyclohexyl(alkyl)amine with a glycidyl ether
10/23/2008US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/22/2008EP1982981A1 Process for production of lasofoxifene or analogue thereof
10/22/2008EP1981849A1 Heterocyclic compounds
10/22/2008EP1981848A2 11-beta hsd1 inhibitors
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981842A2 Sulfonamide derivatives, preparation and therapeutic application thereof
10/22/2008EP1594879B1 Process and intermediates for the preparation of olanzapine
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291957A Novel quaternary polymers
10/22/2008CN101289408A Non-steroid progestogen receptor regulator, preparation thereof, pharmaceutical compositions and uses
10/21/2008US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis
10/21/2008US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
10/21/2008US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer
10/21/2008US7439356 Substituted indan derivatives
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439245 e.g. 1-(3-Phenylsulfonyl-phenyl)piperazine; serotonin receptor modulator; anxiolytic agent, antidepressant, cognition activator; schizophrenia, obesity, Alzheimer's disease
10/21/2008CA2352660C Process for preparing a broad-compatibility, storage-stable, rheologically active urea urethane solution
10/16/2008WO2008124524A2 Aryl sulfonamide compounds as modulators of the cck2 receptor
10/16/2008WO2008124118A1 Benzenesulfonyl compounds and the use therof
10/16/2008WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122667A2 Ureylene derivatives
10/16/2008WO2008076883A3 Triazine derivatives and their therapeutical applications
10/16/2008WO2008021745A3 Hepatitis c virus entry inhibitors
10/16/2008WO2007101007A3 Aryl sulfonyl heterocycles
10/16/2008US20080255360 reacting ethanolamine with ammonia in the presence of a heterogeneous transition metal catalyst and hydrogen, to form a reaction product selected from ethylenediamine, diethylenetriamine, aminoethylethanolamine, piperazine, N-(2-aminoethyl)piperazine, triethylenetetramine and/or mixtures
10/16/2008US20080255345 IRNA Agents Targeting CCR5 Expressing Cells And Uses Thereof
10/16/2008US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255166 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255042 CaSR Antagonist
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1980246A1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
10/15/2008EP1979311A2 Phenoxy acetic acids as ppar delta activators
10/15/2008EP1978959A2 Piperidine and piperazine derivatives
10/15/2008EP1781297B1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
10/15/2008EP1641771B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/15/2008EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives
10/15/2008CN101287703A Pesticide bi-phenyl-amidine derivatives
10/15/2008CN101287702A N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
10/15/2008CN101284791A Electrolytic solution for storage device, and electric double layer capacitor
10/15/2008CN101284790A 离子液体 Ionic Liquids
10/09/2008WO2008120235A1 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
10/09/2008WO2008096075A3 Method for the asymmetric hydrogenation of enamine and device for realising said method
10/09/2008US20080249304 Process for preparing substituted diaminopyrimidine oximes
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/09/2008US20080249086 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction; arrhythmia
10/09/2008US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol
10/09/2008CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/08/2008EP1976842A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
10/08/2008EP1976841A1 Heterocyclic amide derivatives as calcium channel blockers
10/08/2008EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 341